跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NRA-CIPROFLOXACIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NRA-CIPROFLOXACIN
Authorized
STANDARD
NRA-CIPROFLOXACIN
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
aa94c5def7077062
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
aa94c5def7077062
Drug Approval Canada Name
NRA-CIPROFLOXACIN
Product Name
NRA-CIPROFLOXACIN
Status
Marketed
Status Date
2020-12-03
Original Market Date
2020-12-03
Din
02492008
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.18
Atc Original
J01MA02 CIPROFLOXACIN
Atc Name
j 01 ma 02
Aig Number
0123207001
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)
500 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
aa94c5def7077062
Type
Standard
Back to Health Canada Approvals